FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3110654782> ?p ?o ?g. }

• W3110654782 endingPage "e9761" @default.
• W3110654782 startingPage "e9761" @default.
• W3110654782 abstract "Colon cancer remains one of the main cancers causing death in men and women worldwide as certain colon cancer subtypes are resistant to conventional treatments and the development of new cancer therapies remains elusive. Alternative modalities such as the use of viral-based therapeutic cancer vaccine is still limited, with only the herpes simplex virus (HSV) expressing granulocyte-macrophage colony- stimulating factor (GM-CSF) or talimogene laherparepvec (T-Vec) being approved in the USA and Europe so far. Therefore, it is imperative to continue the search for a new treatment modality. This current study evaluates a combinatorial therapy between the oncolytic Newcastle disease virus (NDV) and interleukin-12 (IL-12) cytokine as a potential therapeutic vaccine to the current anti-cancer drugs. Several in vitro analyses such as MTT assay, Annexin V/FITC flow cytometry, and cell cycle assay were performed to evaluate the cytotoxicity effect of recombinant NDV, rAF-IL12. Meanwhile, serum cytokine, serum biochemical, histopathology of organs and TUNEL assay were carried out to assess the anti-tumoral effects of rAF-IL12 in HT29 tumor-challenged nude mice. The apoptosis mechanism underlying the effect of rAF-IL12 treatment was also investigated using NanoString Gene expression analysis. The recombinant NDV, rAF-IL12 replicated in HT29 colon cancer cells as did its parental virus, AF2240-i. The rAF-IL12 treatment had slightly better cytotoxicity effects towards HT29 cancer cells when compared to the AF2240-i as revealed by the MTT, Annexin V FITC and cell cycle assay. Meanwhile, the 28-day treatment with rAF-IL12 had significantly ( p < 0.05) perturbed the growth and progression of HT29 tumor in NCr-Foxn1nu nude mice when compared to the untreated and parental wild-type NDV strain AF2240-i. The rAF-IL12 also modulated the immune system in nude mice by significantly ( p < 0.05) increased the level of IL-2, IL-12, and IFN-γ cytokines. Treatment with rAF-IL12 had also significantly ( p < 0.05) increased the expression level of apoptosis-related genes such as Fas, caspase-8, BID, BAX, Smad3 and granzyme B in vitro and in vivo. Besides, rAF-IL12 intra-tumoral delivery was considered safe and was not hazardous to the host as evidenced in pathophysiology of the normal tissues and organs of the mice as well as from the serum biochemistry profile of liver and kidney. Therefore, this study proves that rAF-IL12 had better cytotoxicity effects than its parental AF2240-i and could potentially be an ideal treatment for colon cancer in the near future." @default.
• W3110654782 created "2020-12-21" @default.
• W3110654782 creator A5001326490 @default.
• W3110654782 creator A5008563366 @default.
• W3110654782 creator A5017139201 @default.
• W3110654782 creator A5020410083 @default.
• W3110654782 creator A5025315418 @default.
• W3110654782 creator A5044209013 @default.
• W3110654782 creator A5051887315 @default.
• W3110654782 creator A5055117068 @default.
• W3110654782 creator A5070195943 @default.
• W3110654782 creator A5076552926 @default.
• W3110654782 date "2020-12-08" @default.
• W3110654782 modified "2023-10-14" @default.
• W3110654782 title "Oncolytic effects of the recombinant Newcastle disease virus, rAF-IL12, against colon cancer cells in vitro and in tumor-challenged NCr-Foxn1nu nude mice" @default.
• W3110654782 cites W1934094702 @default.
• W3110654782 cites W1981418858 @default.
• W3110654782 cites W1982728221 @default.
• W3110654782 cites W1996635399 @default.
• W3110654782 cites W1996996990 @default.
• W3110654782 cites W1997383546 @default.
• W3110654782 cites W1999154897 @default.
• W3110654782 cites W2001256455 @default.
• W3110654782 cites W2002888198 @default.
• W3110654782 cites W2008757142 @default.
• W3110654782 cites W2021359018 @default.
• W3110654782 cites W2023264499 @default.
• W3110654782 cites W2025459290 @default.
• W3110654782 cites W2043744435 @default.
• W3110654782 cites W2044588235 @default.
• W3110654782 cites W2049923191 @default.
• W3110654782 cites W2051263432 @default.
• W3110654782 cites W2055271292 @default.
• W3110654782 cites W2058145479 @default.
• W3110654782 cites W2059493323 @default.
• W3110654782 cites W2063088803 @default.
• W3110654782 cites W2063512646 @default.
• W3110654782 cites W2072930839 @default.
• W3110654782 cites W2074462863 @default.
• W3110654782 cites W2082554712 @default.
• W3110654782 cites W2098733945 @default.
• W3110654782 cites W2108114224 @default.
• W3110654782 cites W2108153325 @default.
• W3110654782 cites W2109508815 @default.
• W3110654782 cites W2121288523 @default.
• W3110654782 cites W2123291849 @default.
• W3110654782 cites W2139594142 @default.
• W3110654782 cites W2154760285 @default.
• W3110654782 cites W2302003756 @default.
• W3110654782 cites W2316101052 @default.
• W3110654782 cites W2343918127 @default.
• W3110654782 cites W2344566829 @default.
• W3110654782 cites W2391651292 @default.
• W3110654782 cites W2510554578 @default.
• W3110654782 cites W2513291255 @default.
• W3110654782 cites W2515707341 @default.
• W3110654782 cites W2527126502 @default.
• W3110654782 cites W2529949558 @default.
• W3110654782 cites W2561259078 @default.
• W3110654782 cites W2563094871 @default.
• W3110654782 cites W2587142197 @default.
• W3110654782 cites W2607235381 @default.
• W3110654782 cites W2608314580 @default.
• W3110654782 cites W2615036427 @default.
• W3110654782 cites W2750536031 @default.
• W3110654782 cites W2771511641 @default.
• W3110654782 cites W2771952185 @default.
• W3110654782 cites W2789732304 @default.
• W3110654782 cites W2790725594 @default.
• W3110654782 cites W2794045287 @default.
• W3110654782 cites W2796181465 @default.
• W3110654782 cites W2799725237 @default.
• W3110654782 cites W2800847969 @default.
• W3110654782 cites W2883452044 @default.
• W3110654782 cites W4245231203 @default.
• W3110654782 cites W4251131797 @default.
• W3110654782 doi "https://doi.org/10.7717/peerj.9761" @default.
• W3110654782 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7731658" @default.
• W3110654782 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33354412" @default.
• W3110654782 hasPublicationYear "2020" @default.
• W3110654782 type Work @default.
• W3110654782 sameAs 3110654782 @default.
• W3110654782 citedByCount "7" @default.
• W3110654782 countsByYear W31106547822021 @default.
• W3110654782 countsByYear W31106547822022 @default.
• W3110654782 countsByYear W31106547822023 @default.
• W3110654782 crossrefType "journal-article" @default.
• W3110654782 hasAuthorship W3110654782A5001326490 @default.
• W3110654782 hasAuthorship W3110654782A5008563366 @default.
• W3110654782 hasAuthorship W3110654782A5017139201 @default.
• W3110654782 hasAuthorship W3110654782A5020410083 @default.
• W3110654782 hasAuthorship W3110654782A5025315418 @default.
• W3110654782 hasAuthorship W3110654782A5044209013 @default.
• W3110654782 hasAuthorship W3110654782A5051887315 @default.
• W3110654782 hasAuthorship W3110654782A5055117068 @default.
• W3110654782 hasAuthorship W3110654782A5070195943 @default.
• W3110654782 hasAuthorship W3110654782A5076552926 @default.
• W3110654782 hasBestOaLocation W31106547821 @default.

• next